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Two new isolates of bovine lentivirus, also known as bovine immunodeficiency-like virus (BIV), were obtained
from a seropositive cattle herd in Florida. This is the first report of new isolates of BIV since the original BIV
strain, R29, was isolated in 1%9. The two new BIV isolates were derived from blood butFy coat cells cocultivated
in vitro with fetal bovine lung cell cultures. The new isolates differed in vitro from the original R29 isolate in
replication and syncytium formation in fetal bovine lung cells. Both new isolates were confirmed as BIV by
immunofluorescence assay, Western blotting (immunoblotting), and polymerase chain reaction. Sequence
analyses of the polymerase chain reaction pol gene product showed 92.6 and 93.670 homology to the published
nucleotide sequence of BIV R29-127, a molecular clone derived from BIV R29. Each of the new BIV isolates was
inoculated into two calves, and virus was recovered between 5 and 10 days postinoculation (p.i.), with BIV
seroconversion between 10 and 21 days p.i. V i s was recoverable and antibody was detectable for at least 4
months p.i. Two calves developed a transiently elevated mononuclear cell count, similar to what was reported for
BIV R29 in the original experimental calf inoculations. No other clinical abnormalities were observed.
The original isolation of the bovine immunodeficiency-like
virus (BIV) was made in 1969 from an &year-old dairy cow
from Louisiana that had a persistent lymphocytosis and was
becoming progressively emaciated. At the time of necropsy,
this cow had clinical and histopathological lesions, including
perivascular cuffing in some vessels in the brain and enlarged
lymph nodes and hema1 nodes (28). The viral isolate from
this dairy cow, designated R29, was originally described as a
visna-like virus because of similarities to the ovine lentiviruse With the finding that human immunodeficiency virus
type 1(HIV-1) is a lentivirus, renewed interest in the bovine
visna-like virus resulted in its molecular characterization,
which conclusively placed BIV in the lentivirus family as a
unique member of the group (4, 10, 11).
BIV causes a persistent infection in cattle, and serological
data i d i c a t e that it may have a
prevalence ( 2 3,
~
13, 14, 29, 30). BIV has a genomic organization similar to
that of other lentiviruses, including thepol,gag, env, and tat
genes (lo, 24). Antigenically, antiserum to BIV P~~ crossreacts with p24 of HIV-1 and antiserum to equine infectious
anemia virus cross-reacts with P~~ and P~~ of BIV ('9'
31).
Two infectious molecular clones of BIV R29, BIV R29-127
and BIV '29-106 have been sequenced, showing that the
virus is a unique member of the lentivirus
(4, lo). BIV
R29-106, however, did not replicate well in cattle after
experimental inoculation (6).
All molecular characterizations and animal inoculation
studies of BIV have been done with the
BIV R29
isolate, which has been passaged
in vitro Or
for Over 20 years, and it may be attenuated (6, 9' lo).
The R29
has
become amtaminated
with a
nOncytO~athic
strain of bovine
diarrhea virus (BVDV).
The original experimental inoculations of BIV R29 in co-

Corresponding author.

lostrum-deprived calves induced mild lymphocytosis and
enlargement of peripheral subcutaneous lymph nodes, with
no overt clinical signs of disease (28). In recent studies with
(i) BIV R29-1203 inoculant free of BVDV, (ii) R29 inoculant
in BVDV-vaccinated cattle, or (iii) BIV R29-106 molecular
clone inoculant, the original experimental findings of leukocytosis and lymph node enlargement have not been observed, suggesting that the virus has become attenuated (6,
10). Attenuation of lentiviruses in cell cultures has been
described in detail for equine infectious anemia virus (5, 25).
However, the virulence of one equine infectious anemia
virus isolate was increased with rapid animal passage (25).
similar experiments with BIV have not resulted in a change
in the course of infection. The BIV R29-106 molecular clone,
is infectious for cell cultures in vitro, was not sustained by animal passage through whole-blood transfer (6,
10).
~,,,1
studies with BIV have explored the possibility
that this virus causes immune system alterations, similar to
HIV-l or feline immunodeficiency virus. However, because
the original BIV isolate, R29, has become contaminated with
a noncytopathic strain of BVDV, an RNA virus that can
cause immune suppression in bovines, interpretation of data
acquired from cattle inoculated with this isolate has become
complicated (6, 21). studies examining immune function of
BIV in vivo have demonstrated either mild or no immunosuppression on the basis of lymphocyte blastogenesis tests,
neutrophil function tests, mononuclear subset analysis, and
histopathological ,-hanges (6, 8, 21). Available research
results have not shown that BIV is a disease-causing agent in
cattle in experimental inoculations. These reports were all
based on studies of cattle infected for less than 27 months (6,
28-30). Thus, the Dossibilitv that BIV has a long
8,
incubation period before causing disease or that it has the
ability to act as a cofactor in disease cannot been ruled out
(6, 29).
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In this report, we describe the in vitro and in vivo
characterization of two new wild-type isolates of BIV which
were isolated from two cows in a seropositive dairy herd in
Florida. A BVDV-free BIV isolate of R29, BIV R29-1203,
was also used in this study as a positive control to help
contrast the differences between the new isolates and R29derived isolates. The R29-1203 isolate was prepared by
vaccinating a BIV-BVDV-negative calf with an autogenous
BVDV vaccine prepared (S. R. Bolin, National Animal
Disease Center, Ames, Iowa) from a clone of the noncytopathic BVDV isolated from BIV R29 cell cultures. After the
calf developed neutralizing antibodies to BVDV, it was
inoculated with BIV R29. BIV was recovered from blood
buEy coat cells, tested both in vitro by cell culture methods
and in vivo by calf inoculation, found to be free of BVDV,
and designated BIV R29-1203.
In vitm characterization of BIV isolates. A Florida dairy
herd with BIV-seropositive cattle was identified by Western
blot (immunoblot) assay, and blood samples in EDTA tubes
were taken for virus isolation (31). The blood samples were
centrifuged, and the buEy coat cells were removed for
coculture with fetal bovine lung cells cultured in Eagle's
minimum essential medium with Earle's salts supplemented
with 10% fetal bovine serum, Polybrene (4 pg/ml), gentamicin (50 pg/ml), and 0.02% L-glutamine. These cultures
were blind passaged and/or cultured with fresh fetal bovine
lung cell cultures until the cytopathic effects of syncytium
formation and cell lysis were observed. Evidence of viral
replication by syncytium formation was observed in two
cultures, FL491 and FL112, after the fourth blind passage in
culture. The two cows from which the isolates were derived
were seropositive for BIV on Western blot assay and seropositive for bovine leukemia virus (BLV) and seronegative
for bovine syncytial virus (BSV) on agar gel immunodifision
(AGID) (19, 22, 31). Continued culturing of FLA91 and
FL112 gave increased syncytium formation with limited cell
lysis. The new isolates showed differences in replication
characteristics in vitro compared with BIV R29, including
higher cocultivation ratios, longer incubation times between
passages, and differences in &cytial appearance typified by
a decreased number of nuclei per syncytium and greater
granularity and slower lysis of {he s$c$ia
cornparid with
BIV R29 and BIV R29-derived isolates. Syncytial nuclei
from the new wild-type isolates often formed a circular
pattern in culture which was not commonly observed in BIV
R29-derived cultures. The BIV R29-1203 isolate demonstrated higher cytopathogenicity in cell culture than did the
new isolates. The FL491 and FL112 wild-type isolates had
similar replication patterns in vitro with smaller syncytia and
a less lytic effect on cell cultures. The replication characteristics of the different BIV isolates were maintained in relation to their parent strain after animal inoculation.
The new wild-type isolates of BIV have biological differences in comparison with R29 in vitro, and in vitro characteristics of other lentiviruses have been shown to correlate
with virulence in vivo (7). Specifically, the more cytopathogenic lentiviral strains in culture are associated with greater
in vivo virulence in HIV-1 and greater lymphoproliferative
change in the ovine lentivirus maedi-visna virus (7, 12, 16,
17). Different regions of the viral genomes have been associated with these in vitro and in vivo characteristics (9, 12,
23,32). Biological variation should not be unexpected among
BIV isolates, and these differences are probably controlled
by several different areas of the genome.
FL491 and FL112 were BIV positive by immunofluorescence assay using BIV-specific antiserum and fluorescein-

NG. 1. Products of PCR amplification (left) of a 242-bp segment
of the pol gene from BIV R29-1203 (lanes l), BIV FLA91 (lanes 2),
and BIV FL112 (lanes 3) and Southern blot hybridization (right) of
those products with a 32P-labeledpolgene probe. Negative (lanes 4)
and positive (lanes 5) PCR controls and a molecular size ladder are
also shown.

conjugated rabbit anti-bovine immunoglobulin G, but both
isolates were indirect immunofluorescence assay negative
for BLV and BSV by the same technique (30). Western blot
assays using viral antigen prepared as previously described
(31) from each of the isolates with positive reference control
sera were positive for BIV, negative for BLV, and negative
for BSV. AGID tests using positive reference sera for BLV
and BSV were negative (data not shown) (19, 22). DNA
samples for polymerase chain reactions (PCR) were prepared from BIV-infected fetal bovine lung cell cultures with
proteinase K followed by phenol-chloroform extraction by
standard procedures (20). One microgram of template DNA,
20 pmol of primer, and 1.25 U of Tag polymerase (Cetus
Corp., Norwalk, Conn.) in a 50-p1 reaction mixture were
used in a standard PCR mixture with first-cycle conditions of
94°C for 2 min, 51°C for 15 s, and 72°C for 2 min and then 30
cycles of 94°C for 45 s, 51°C for 15 s, and 72°C for 1min and
a final extension step of 72°C for 10 min. The pol gene
plus-sense primer 5' ATG CTA ATG GAT TIT AGG GA 3'
and the minus-sense primer 5' CAT CCT TGT GGT AGA
ACA TT 3' amplified a 242-bp product from BIV R29-1203-,
FL491-, and FL112-infected cell cultures (Fig. 1) whose size
was predicted by published sequence data and previously
reported work (10, 15). Southern blot analyses with the BIV
pol gene-specific probe confirmed the identities of the PCR
products (20). Each PCR product was then directly sequenced by purification with a Centricon 100 microconcentrator and use of 40 ng of DNA with Tag polymerase in a dye
terminator sequencing system on an automated sequencer
(ABI Applied Biochemistry 373A DNA Sequencer; performed at the Nucleic Acid Center, Iowa State University,
Ames). Nucleotide sequences were analyzed for homology
by using the Wilbur-Lipman methods (DNASTAR program
Align). The 212-bp sequenced PCR products were compared
to the published sequence for the putative reverse transcriptase gene segment of BIV R29-derived molecular clone
BIV R29-127 (10). The BIV R29-1203 isolate had 99.6%
nucleotide sequence homology with the published sequence,
with only a single, silent nucleotide substitution. The BIV
FL491 and FL112 isolates had 93.6 and 92.6% nucleotide
sequence homology, respectively, to the published BIV
sequence and 96% nucleotide sequence homology with each
other. All of the sequenced products maintained the same
open reading frame for a segment of the putative reverse
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transcriptase gene, and no insertions or deletions were seen
in the sequenced product. The predicted amino acid homologies for BIV FL491 and FL112 were 93.8 and 92.3%,
respectively.
The reverse transcriptase region of the genome is highly
conserved among other lentiviruses, and it is expected that
BIV is similar. Comparison of thepol gene region of the BIV
R29-1203 isolate, which has been through an animal passage
and over 35 passages in cell culture, to the published
sequence for BIV R29-127, a molecular clone of BIV R29,
demonstrated that BIV R29-1203 has only a single, silent
nucleotide change from the published sequence. This suggests that this segment of the reverse transcriptase region
may be highly conserved in BIV and provides a valuable
guidepost for comparison of new isolates. The new Florida
isolates have 7 to 8% nucleotide sequence divergence in the
conserved pol segment compared with Louisiana BIV R29127, demonstrating the divergence of these isolates from
R29. The new isolates have only 4% nucleotide sequence
divergence between them, suggesting that they are more
closely related field isolates. Comparisons of different
HIV-1, visna virus, and feline immunodeficiency virus isolates show that the diversity of nucleotide sequences of
isolates generally is greatest when they are from geographically distinct populations (1, 18, 26,27). In comparison with
these three lentivirus groups, the new Florida BIV isolates
appear to be distinct from the Louisiana isolate but are not as
divergent as other geographically distinct lentivirus isolates.
Sequencing of other BIV isolates will help to determine
whether the Florida isolates are distinct or continuurns of the
same BIV population.
In vivo characterization of BIV isolates. Four calves negative for antibodies to BIV, BLV, and BSV were experimentally inoculated with the FL491 and FL112 isolates. Each
calf received BIV-infected fetal bovine lung cells and culture
fluids intravenously in the jugular vein and subcutaneously
in the area around the jugular vein as follows: BIV FL491,
Jersey calf 1268 and Holstein calf 848; BIV FL112, Jersey
calves 1275 and 1269. Calves were observed for clinical
symptoms, and blood samples were taken at 3, 5, 7, 10, 14,
21, and 28 days postinoculation ( p i ) for virus isolation,
serology, and leukocyte (WBC) differential counts. Thereafter, the calves were sampled weekly for serologic and WBC
responses and every 2 to 4 weeks for virus isolation.
All four calves developed BIV-specific antibody responses
as determined by Western blot analysis. Results of Western
blotting of serum samples from calf 1275 taken preinoculation, on p.i. day 35, and on p.i. day 91 and from calf 1268
taken preinoculation, on p.i. day 35, and on p.i. day 105 are
shown in Fig. 2B. Calves 1268 and 848, inoculated with BIV
FL491, developed a BIV-specific serological response starting at p.i. days 10 and 20, and virus was recovered from
samples starting on p.i. days 10 and 11, respectively. Calves
1275 and 1269, inoculated with BIV FL112, both developed
a BIV-specific serological response starting at p.i. day 14,
and virus was isolated from samples by p.i. days 5 and 7,
respectively. Viral antigens prepared from virus recovered
from experimentally inoculated calves 1268 and 1275 were
used in a Western blot (Fig. 2A) and were positive with BIV
reference sera. Western blot antigens were also tested with
both BLV and BSV reference sera and were negative (data
not shown).
The WBC response for calves 1275 and 1269, inoculated
with FL112, showed transient leukocytosis consisting
mainly of mononuclear cells (Fig. 3). The WBC response for
calves 1268 and 848, inoculated with FL491, was slightly
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FIG. 2. (A) Western blot assay in which BIV reference serum
was reacted with viral antigens prepared from BIV R29-1203 (lane
l), BIV FLQ91 (lane 2), an isolate of FL491 from calf 1268 (lane 3),
BIV FL112 (lane 4), and an isolate of FL112 from calf 1275 (lane 5).
Molecular weight markers (MWM) are indicated on the left in
thousands. (B) Western blot assays of serum samples from calf 1268,
which had been inoculated with BIV FL491, taken preinoculation
(lane I), on day 35 p.i. (lane 2), and on day 105 p.i. (lane 3) and
serum samples from calf 1275, which had been inoculated with BIV
FL112, taken preinoculation (lane 4), on day 35 p.i. (lane 5), and on
day 91 p.i. (lane 6). Molecular weight markers are shown on the left.
The 20-kDa band in pre- and postinoculation serum samples from
both calves is not BIV specific.

increased, with an increased percentage of mononuclear
cells, but remained within the normal range (Fig. 3). The
calves had the expected prescapular lymph node enlargement on the side on which the inoculation materials were
injected but showed no other clinical symptoms.
Preinoculation sera from all calves were negative for
neutralizing antibodies to BVDV, BLV, and BSV, except for
calf 848, which had neutralizing antibody to BVDV. After
inoculation with BIV, the three BVDV-seronegative calves
remained negative for virus-neutralizing antibodies to
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FIG. 3. Comparison of mononuclear (Mono) and polymorphonuclear (PMN) cell counts in two calves inoculated with BIV FL112
(calves 1275 and 1269) or BIV FL.491 (calves 1268 and 848). Calves
1275 and 1269 showed the greatest mononuclear cell increase,
similar to the WBC increase reported in the original experimental
inoculations with BIV R29 (31). No changes in the polymorphonuclear cell population were observed for either calf.

BVDV. AGID tests for antibodies to BLV and BSV also
remained negative for multiple samples taken from all calves
from weeks 7 through 14 p.i.
The new isolates in experimental inoculations caused a
leukocytosis similar to that described in the original experimental inoculations with BIV (28). More cattle need to be
inoculated to confirm the initial finding that these new
isolates cause leukocytosis, to rule out the possibility of
biological variation among cattle. These studies may provide
further insight into the question of possible attenuation of the
BIV R29 isolate and verify that BIV does cause leukocytosis. Results from the current study, as well as from future
studies performed with these new wild-type isolates, should
provide a clearer picture of the true effect of experimental
inoculation with BIV.
In conclusion, this study provides information on the
biological and genetic characteristics of BIV and provides
new BIV isolates for experimental study. Since it is possible
that the original BIV R2Y isolate was attenuated through
multiple cell culture passages, these new, low-passage,
contaminant-free isolates will allow measurements of possible immune suppression in vivo that may more accurately
reflect a natural infection. The new isolates of BIV are
important for continued investigation of the pathogenesis of
BIV infections and elucidation of the potential role of BIV as
a disease agent or a cofactor in disdase. The new isolates
increase the potential value of BIV as an animal model for
lentivirus infections.
Nucleotide sequence accession numbers. The GenBank accession numbers for the nucleotide sequences reported here
are LO6524 (BIV FL112), LO6525 (BIV FL491), and LO6526
(BIV R29-1203).
We thank Janet Warg, Dennis Orcutt, and Lea Ann Middle for
technical support;-Gene Hedburg, Tom Glasson, and Wayne Romp
for photographic assistance; and Susan Carpenter, Bruce Seal,
Steven Bolin, and Mary Jo Schmerr for critical review of the
manuscript.
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